Omega Point · Hypothesis

Dominant recalled immune cells can sustain infection by killing local support cells

In a subset of older adults, recalled cytotoxic T cells may sustain tissue infection by killing uninfected dendritic cells. In autologous infected tissue cultures, removing the dominant population must improve presenter survival before pathogen control; adding it back must reverse rescue.

Proxy gapEffector induced support cell deletionRepertoire Renewal–Retention Competition and Selectivity Failure Resistance2 rival hypothesespublished 2026-09-21

014 stages from the goal to this hypothesis

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the explanation proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

An aging immune system might retain cells that recognize an infection yet fail to control it where it lives. The unexpected move is that allowing more of the dominant remembered defenders into the affected tissue could make protection worse because they destroy cells that support other defenses. This is a proposal generated by the pipeline, not a measured result in older adults.

The proposed mechanism, link by link

A previously activated, dominant group of cytotoxic T cells encounters uninfected dendritic cells displaying the target it recognizes.
The dominant group is proposed to kill those support cells faster than it kills infected cells.
Loss of dendritic cells deprives other protective immune cells of support.
Replacement dendritic cells are repeatedly destroyed, turning replacement from recovery into continuing support loss.
Temporarily excluding the dominant group is predicted to let dendritic cells survive and existing alternative defenses control infection.
Returning the dominant group, or increasing its local access, is predicted to restart support-cell destruction and worsen control.

A picture for it

A security team keeps removing the dispatchers who show it photographs of intruders, leaving other guards without coordination. Hiring replacement dispatchers cannot solve the problem while the same team keeps removing them.

Where the picture breaks: Immune cells do not mistake photographs for people or make deliberate decisions. The biological claim depends on recognition of displayed antigen, actual killing of uninfected support cells, and other defenses requiring those cells.

Master questionstep 01 of 04
Durable immune restoration in older people would require both innate immunity, the body's broadly acting defenses, and adaptive immunity, defenses directed at particular targets, to function within healthy young-adult ranges. It must also preserve immune memory, protection retained from previous encounters; self-tolerance, avoidance of attacks on the body's own tissues; and control of latent infections, infections that persist without continuously causing active disease.
Rests on: The goal itself defines successful restoration as improved function together with preservation of existing protection. It asks which conditions are necessary and sufficient together; it does not establish that such restoration is achievable.
Stated in the chain
Goal pillarstep 02 of 04
Renewing the immune repertoire, the collection of targets immune cells can recognize, is framed as competing with retaining existing protection. The pillar also names resistance to failures of selectivity, meaning failures to favor useful responses over harmful ones, but supplies no operational definition.
Rests on: The master goal requires improved immune function while preserving immune memory. The pillar adds competition between renewal and retention and a role for selective failure.
Assumption
The supplied pillar assumes that renewal–retention competition and failures of selectivity organize the restoration problem; the master question does not establish those relationships.
Gap questionstep 03 of 04
Better blood measurements could coexist with poor protection in particular tissues. The gap question contrasts missing specificities, immune recognition of particular targets, with failure to reach supportive tissue locations, and asks whether restoring access could recover protection without generating new clones, groups of immune cells descended from a shared parent cell.
Rests on: The pillar's concern with renewing recognition while retaining protection motivates asking whether existing cells can suffice. It does not itself describe improved blood measurements alongside tissue failure or establish access as the competing explanation.
Assumption
The question takes improved blood measurements with continuing tissue protection gaps as its setting and assumes that missing recognition and inadequate local access are relevant alternatives.
Hypothesisstep 04 of 04
In a proposed subset of older adults, recalled cytotoxic T cells, immune cells reactivated by a previously encountered target and capable of killing other cells, destroy uninfected dendritic cells, cells that display target fragments and support immune responses. Those dendritic cells bear antigen, material recognized by immune cells, despite being uninfected. The proposal predicts that repeated destruction of replacement support cells sustains infection, so temporarily excluding the dominant recalled group allows other existing defenses to regain control.S1 S6
Rests on: The preceding question supplies the possibility of restoring protection with existing cells. Nature Communications (2020), S1, reports that dendritic cells can protect themselves from activated T-cell killing in mouse tumor models, but does not establish the proposed older-adult infection mechanism. The Journal of Immunology (2011) abstract, S6, reports that removing dendritic cells during an influenza response reduces infection-directed T-cell responses and viral clearance, but does not establish destructive recall or rescue by excluding a dominant group.
Supported by literature

What is carried, and what is not. Screened sources speak to two component links: activated T cells can threaten dendritic-cell survival, and dendritic-cell loss can weaken infection-directed responses. Those findings come respectively from the mouse tumor work in Nature Communications (2020), S1, and the influenza study available here only as an abstract in the Journal of Immunology (2011), S6; neither establishes the proposed sequence in older adults, and no supplied source establishes it end to end.S1 S6

Where the reasoning is carried by something unstated · 2

Goal pillar. The supplied pillar assumes that renewal–retention competition and failures of selectivity organize the restoration problem; the master question does not establish those relationships.
Gap question. The question takes improved blood measurements with continuing tissue protection gaps as its setting and assumes that missing recognition and inadequate local access are relevant alternatives.

How a result here could mislead · 3

Improved infection control after removing the dominant group could be credited to preventing support-cell killing even if removal instead relieves the rival mechanism of delayed depletion of local nutrients. Returning the group and losing protection again would not alone separate those routes. What closes it: The proposed imaging must establish direct killing of uninfected dendritic cells and improved survival before improved infection control. Distinguishing the nutrient rival also requires measuring local nutrient changes over time or a comparison that prevents support-cell killing while retaining the dominant group; neither additional comparison is specified.
Failure to improve after selective removal could mean that the mechanism is wrong, or that enough of the targeted group remained to continue destroying replacement dendritic cells. What closes it: Removal efficiency and the identity of remaining cells must be measured, alongside continuing dendritic-cell death across repeated challenges. The supplied design gives no criterion for adequate removal.
Rescue in a tissue culture could be interpreted as excluding the rival in which incoming protective cells die at the blood-vessel lining, even though the culture may bypass that entry route. What closes it: The test must establish whether it preserves entry through a blood-vessel lining and measures cell survival during entry. If it does not, culture rescue cannot rule out the entry-associated death mechanism in intact tissue.

What would make this wrong. The proposed chain would fail in the tested setting if effective selective removal of the dominant group stopped its killing of uninfected dendritic cells and restored their survival, yet existing alternative defenses still failed to improve infection control across repeated challenges. Improved control that persisted after removal of dendritic cells would separately contradict the claim that their survival is required for rescue.

What it would change. If the mechanism held, restoring youthful immune protection would sometimes require restraining a dominant remembered response so that other existing defenses can work. Increasing cell numbers or tissue access would then need to account for which cells receive that advantage. Accessible tissue cultures would still not establish durable restoration across the body, safety of removing these cells throughout the body, or preservation of immune memory, self-tolerance, and latent-infection control. The claimed stabilization of SPV_7 cannot be interpreted because the supplied material does not define that measure.

Sources read · 8

4 literature searches, 8 full texts, 2 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Partly answers it

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade. · Nature communications · 2020

“PD-L1 on DCs is upregulated during antigen-presentation to protect DCs from cytotoxicity of activated T cells. However, such effect also dampens the antitumor immune responses.”

Does not settle: This source concerns antitumor responses in mouse models. It does not establish the proposed infection setting, older-adult population, recalled specificity, preferential killing of uninfected antigen-bearing DCs over infected targets, repeated replacement-presenter destruction, exclusion of a dominant specificity, SPV_7, or preservation of protection elsewhere.

S3Background

Cytotoxic T Lymphocyte Activation Signals Modulate Cytoskeletal Dynamics and Mechanical Force Generation. · Frontiers in immunology · 2022

“Cytotoxic T lymphocytes (CTLs) play an integral role in the adaptive immune response by killing infected cells. Antigen presenting cells (APCs), such as dendritic cells, present pathogenic peptides to the T cell receptor on the CTL surface and co-stimulatory signals required for complete activation.”

Does not settle: This murine primary CTL study does not establish recalled CTL killing of uninfected antigen-bearing dendritic cells, discordant tissue infection in older adults, comparative killing rates, loss of support for other effectors, exclusion of a dominant specificity, SPV_7 stabilization, or preservation of protection elsewhere.

S4Background

CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function. · Oncotarget · 2017

“In this study, we demonstrated for the first time that CTLA-4 expressed on breast cancer cells was functional and CTLA-4 + BCCs played an inhibitory role on the maturation and function of DCs, which was CTLA-4-dependent.”

Does not settle: This source does not examine older adults, tissue infection, recalled cytotoxic T cells killing antigen-bearing dendritic cells, replacement presenters, exclusion of a dominant specificity, SPV_7, or restoration of infection control.

S5Background

Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway. · Aging cell · 2010

“blockade of the PD-1/PD-L1 pathway did not restore function of PD-1 + T cells; its effect appeared to be exclusively mediated by increased functionality of the PD-1 − T cells.”

Does not settle: This aged-mouse study does not examine discordant tissue infections, recalled cytotoxic T-cell killing of uninfected antigen-bearing dendritic cells, presenter replacement, temporary exclusion of a dominant specificity, alternative effector-mediated control, or SPV_7 stabilization.

S6BackgroundAbstract only

Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. · Journal of immunology (Baltimore, Md. : 1950) · 2011

“Depleting DCs or blocking CD28 after day 6 of primary influenza A virus infection decreases the virus-specific CD8(+) T cell response by inducing apoptosis, and this results in decreased viral clearance.”

Does not settle: It does not establish the proposed phenomenon in older adults, discordant tissue infections, recalled dominant cytotoxic specificities killing uninfected antigen-bearing dendritic cells, comparative killing rates, exclusion of a specificity, SPV_7, or preservation of protection elsewhere.

S7Contradicts it

Interleukin-17D Promotes Pathogenicity During Infection by Suppressing CD8 T Cell Activity. · Frontiers in immunology · 2019

“CD8 T cell depletion in IL-17D-deficient mice restored the bacterial burden to a level similar to that found in WT mice.”

Does not settle: This mouse study does not establish the proposed mechanism of recalled cytotoxic T cells killing uninfected antigen-bearing local dendritic cells, effects in older adults or discordant tissue infections, temporary exclusion of a dominant specificity, SPV_7, or preservation of protection elsewhere.

S9BackgroundQuote unverified

Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation. · Cellular and molecular life sciences : CMLS · 2022

“Concluding, our data show that PERK activation is crucial for SBA-induced DC cross-presentation.”

Does not settle: It does not examine older adults, tissue infection, recalled cytotoxic T-cell killing of dendritic cells, relative killing of infected versus uninfected targets, exclusion of a dominant specificity, SPV_7, or restoration of infection control.

S10Background

CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. · Cancer immunology research · 2020

“cDC1, which cross-present tumor antigens to CD8 + T cells, are essential for antitumor immune responses ( ).”

Does not settle: This source does not establish the proposed infection-specific mechanism, recalled cytotoxic T-cell killing of uninfected dendritic cells, effects of excluding a dominant specificity, or preservation of protection elsewhere.

02The unknown

The gap this hypothesis explains

What is measured here stands in for what matters, and may not track it.

Do protection failures reflect missing recognition or blocked tissue access, and can restoring access rescue existing immune cells?

Original wording · exactly as the pipeline generated it

The gap question, as the engine wrote it

When blood repertoires and functional panels improve, do emerging protection gaps follow absent specificities or inaccessible tissue niches, and can restoring local access rescue function without generating new clones?

What this question is asking

The question concerns why people with age-related immune dysfunction might remain poorly protected even when blood tests suggest improvement. It asks whether the immune system lacks cells that recognize a particular threat, or whether suitable cells exist but cannot reach the tissue locations where protection is needed. The proposed intervention is to restore that local access, comparing protection before and after while establishing whether new immune-cell clones were generated. The question assumes that improved blood repertoires and fixed functional panels can coexist with failures of protection, and that missing recognition and failed local deployment can be distinguished as causes.

What the terms mean

Age-related immune dysfunction: Changes associated with aging that reduce how well the body's defenses work. The question concerns people with these changes, but the supplied material does not define a single diagnostic threshold.
Protection gap or clinical protection failure: A situation in which immune defenses do not provide the protection being assessed. The input does not specify a particular infection, tissue, severity measure, or time period.
Immune specificity or threat recognition: The particular target an immune recognition system can detect. Missing specificity means that recognition of a relevant target is absent, rather than simply that the overall number of immune cells is low.
Blood repertoire: The collection of immune recognition types detected in a blood sample. Its membership or diversity is a measurement of sampled recognition types, not a direct measurement of protection throughout the body.
Functional panel: A selected set of tests measuring immune activities. A fixed panel covers its chosen activities; the input does not establish which activities were tested or what improvement means.
Tissue niche, local access, and deployment: A tissue niche is a local setting within an organ or body tissue where immune cells may need to operate. Access concerns reaching that setting, while deployment concerns being present where the needed response occurs; neither term alone establishes that cells survive or function there.
Immune-cell clone and lineage: A clone is a family of immune cells descended from a common starting cell; a lineage describes their related ancestry. Rescue without new clones means that improvement must be accounted for by existing families rather than newly generated ones.
Antibody and antibody-secreting cell: An antibody is an immune protein that recognizes a target, and an antibody-secreting cell releases these proteins. S7 measures such cells in blood after vaccination, which does not by itself establish where they subsequently act.
Naive repertoire and intralineage diversification: The naive repertoire comprises recognition types available among cells that have not yet entered a response to their matching target. Intralineage diversification means variation developing within related cell families; S1 describes reduced availability of the former and reduced fine-tuning through the latter in older participants.
T cell and T-cell receptor repertoire: A T cell is a type of immune cell whose receptor participates in recognizing targets. The receptor repertoire is the collection of recognition types across these cells, which S2 describes as contracting with age.
Tissue-resident memory T cell: A T cell associated with lasting immune memory that remains in a tissue. Its local presence, survival, target recognition, and protective activity are distinct properties in this question.
Plasma and brain white matter: Plasma is the liquid portion of blood. White matter is brain tissue containing nerve-fiber connections; S6 reports immune-cell accumulation there after mice received plasma.
Mucosal tissue and immunoglobulin A: Mucosal tissues line surfaces such as the respiratory and digestive passages. Immunoglobulin A is a class of antibody; S9 reports its induction in the nose after vaccination through the nose.
Vaccination route: The way a vaccine enters the body, such as through the mouth, through the nose, or into muscle. S9 compares routes, which does not isolate restoration of access for already existing cells.
Preclinical study: Research conducted before establishing an effect in humans. The supplied description identifies S9 as preclinical and explicitly says it does not establish the requested result in humans.

What the question takes for granted

Premise not found in what was read

Apparently successful renewal, reflected in improved blood repertoires and functional panels, can conflict with clinical protection, and the resulting protection gaps can be distinguished as absent specificities versus failed local deployment.

Blood repertoires describe the collection of immune recognition types found in blood, while functional panels test a selected set of immune activities. The assumption is that these measurements can improve while protection still fails because either the necessary recognition is missing or suitable cells cannot reach the tissue that needs them. If established, this would explain why favorable blood measurements might leave a specific protective requirement unmet.

The supplied searches did not return evidence establishing this particular mismatch after apparent renewal or the proposed distinction between its causes. S1 reports age-related changes in blood antibody repertoires, S6 reports immune-cell accumulation alongside a marker involved in cell movement, and S9 reports different local immune responses after different vaccination routes. None establishes the asserted sequence of improved blood measurements followed by a protection failure attributable to one of the two proposed causes. This bounded set does not show that the premise is false.S1 S6 S9

The same question asked without the part nothing read establishes:

When protection fails despite improved blood immune measurements, is relevant threat recognition absent, is tissue access limited, or are both involved?
Can restoring tissue access improve protection using existing immune-cell clones without generating new ones?

What turns on the answer

The necessary recognition is missing Under this explanation, the existing cells cannot recognize the threat responsible for the protection failure. Restoring access alone would therefore leave that missing recognition unresolved, even if more cells reached the tissue.
Existing cells are blocked from the tissue Under this explanation, cells with the necessary recognition already exist but cannot reach the relevant location. If access is the limiting step, restoring it could improve protection without generating new clones; the supplied sources do not demonstrate this rescue.
Both limitations contribute, or neither is sufficient Restoring access could leave missing recognition unresolved, while having suitable recognition could leave local deployment unresolved. A protection failure would then resist explanation by the proposed either-or distinction, and improved blood measurements alone would not identify the remaining limitation.

Why it matters

Recognizing a threat and providing protection where it occurs are separate steps in the mechanism proposed by the question. If suitable cells are absent, allowing existing cells into a tissue would not by itself supply the missing recognition. If suitable cells already exist but cannot reach the relevant location, improved access could potentially let them provide protection. Mistaking either situation for the other could lead to treating a better blood-test result as restored protection while the limiting step remains unresolved. These are conditional consequences of the question's proposed mechanism, not outcomes established by the supplied sources.

What is already established

Sequencing and fixed panels sample membership or selected functions; RL-1/2 compartmental methods reveal localization but leave substantial coverage unverified.

What would have to be true

Local protection must exceed separate limits; discordant events must trigger expanded assessment before the next routine interval despite favorable aggregate results.

What is missing

No validated causal test distinguishes absent specificity from failed local deployment when apparently successful renewal conflicts with clinical protection.

03The claim

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

In a subset of older adults with discordant tissue infections, abundant recalled cytotoxic T cells destroy uninfected, antigen-bearing local dendritic cells faster than they eliminate infected targets. This removes the cellular support required by other protective responses. The maladaptive state is sustained by repeated destruction of replacement presenters, rather than absent protective receptors. Increasing local access of the dominant recalled specificity worsens protection; temporarily excluding that specificity permits existing alternative effectors to restore control. Preventing this destructive interaction stabilizes SPV_7 while preserving established protection elsewhere.

04The test

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

In autologous infected tissue cultures, selectively removing the dominant event-associated cytotoxic population reduces viable pathogen burden across repeated challenges despite reducing cognate cytotoxic-cell abundance. Live imaging must show that presenter survival improves before pathogen control improves. Adding the same population back restores presenter loss and impaired control. Removing presenters from the rescued culture abolishes rescue. Access enhancement or addition of more cells with the dominant specificity instead worsens control. These outcomes distinguish destructive recall from insufficient access, nutrient suppression, and a missing-specificity explanation.

Would tell it apart from at least one rival. Separates 2 of 2 rivals on the result their predictions give. A paper already fetched for this hypothesis bears on it.

05The contest

What it is competing with

Every other explanation the engine wrote for the same gap, and the observation that would separate the two.

This explanation predicts

Rival 01 of 02
Delayed nutrient depletion causes recurring gaps in local immune protection
What would separate them
Delayed nutrient depletion causes recurring gaps in local immune protection predicts: During repeated challenge, local effector activity rises before IDO1 activity rises and tryptophan falls; loss of protection follows that trough. A phase-targeted tryptophan clamp restores protection more effectively than an equal-total supplement delivered outside the trough, with receptor membership and cellular access held constant. Rescue must persist when kynurenine exposure is experimentally matched. Directly placing additional competent cells in the tissue fails during the trough, whereas existing cells recover after nutrient restoration. Failure to detect the predicted ordering or phase dependence rejects the delay mechanism.
Rival 02 of 02
The blood vessel lining kills protective immune cells as they enter tissue
What would separate them
The blood vessel lining kills protective immune cells as they enter tissue predicts: In a perfused endothelial–tissue preparation, event-reactive cells undergo caspase activation at the endothelial interface before accumulating in tissue. Endothelial-restricted FasL interruption restores viable entry and pathogen control. Direct placement of the same cells beyond the interface produces equivalent rescue without changing their receptors. Adding more relevant cells upstream fails, while unrelated-specificity controls do not rescue. Nutrient restoration alone does not prevent entry-associated death.

06The bench

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Antigen-reactive populations can be enriched or depleted in research cultures, followed by matched add-back and presenter-depletion experiments. Live imaging can distinguish death of infected targets from death of uninfected presenters. Initial tests require accessible tissue and cannot establish safety of systemic depletion.

07The standing

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

Antigen-bearing dendritic cells were eliminated in peripheral tissues through perforin-dependent cytotoxicity, limiting subsequent stimulation: [Perforin-dependent elimination of dendritic cells regulates CD8 T-cell expansion](https://pmc.ncbi.nlm.nih.gov/articles/PMC1324995/). Separately, restricting T-cell cytotoxicity improved dendritic-cell vaccination and tumor rejection: [Inefficient boosting is rescued by restricting cytotoxic functions](https://pmc.ncbi.nlm.nih.gov/articles/PMC3525606/). Neither study establishes the proposed older-adult infection mechanism.

Subfield revised

Tissue-memory immunology: the textbook chapter 'Effector mechanisms of cell-mediated immunity and protective immunological memory.' The proposed revision is that locally abundant, pathogen-specific recall can be a net cause of persistent infection, with sustained control improving after its selective local removal.

Testable surprise

Removing the dominant pathogen-specific tissue killers produces sustained improvement in viable-pathogen clearance, while adding them back reverses that improvement, without recruiting any new receptor specificity.

Why this is not the mainstream account

Not established. Presenter killing and its negative regulation of immune responses are already known. The proposed heretical extension is sustained improvement of tissue pathogen control after removal of the dominant pathogen-specific cytotoxic population in older adults. The targeted search did not establish that extension, but cannot prove its absence from all reviews; this is a provisional HERETICAL candidate.

08The provenance

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteA paper already fetched for this hypothesis bears on it

What it would take to refute it. 6 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Distribution of Uropathogens and Molecular Characterisation of Virulence Genes of Uropathogenic <i>Escherichia coli</i> (UPEC) in Catheter-Associated Urinary Tract Infections in Limpopo Province, South Africa.; A Multi-Axis Framework for Late-Life Alzheimer's Disease Interpretation.; Comparison of OneChoice AI-Based Clinical Decision Support Recommendations with Infectious Disease Specialists and Non-Specialists for Empirical Urinary Tract Infection Therapy in Lima, Peru..

6 papers retrieved around this hypothesis

Distribution of Uropathogens and Molecular Characterisation of Virulence Genes of Uropathogenic <i>Escherichia coli</i> (UPEC) in Catheter-Associated Urinary Tract Infections in Limpopo Province, South Africa.PMID 42654795 · full_text · 97397 characters stored
Infections in Infancy and Association with Long-Term Weight Gain and Obesity in Children, Southern California, USA.PMID 42521475 · full_text · 40166 characters stored
Vaginitis and Sexually Transmitted Infections Coinfections.PMID 42499792 · full_text · 33797 characters stored
SARS-CoV-2 IgG seropositivity among people living with and without HIV in the first year of the COVID-19 pandemic in Haiti and Tanzania.PMID 42502750 · full_text · 39626 characters stored
Comparison of OneChoice AI-Based Clinical Decision Support Recommendations with Infectious Disease Specialists and Non-Specialists for Empirical Urinary Tract Infection Therapy in Lima, Peru.PMID 42739140 · full_text · 59009 characters stored
A Multi-Axis Framework for Late-Life Alzheimer's Disease Interpretation.PMID 41893025 · full_text · 66142 characters stored

0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.

This is a proposed explanation, not a finding. It was written by the Omega Point engine from the literature it was given, it has not been tested, and no experiment here has been run. The numbers, methods and citations in it are model-generated and unverified. Its name was written by the Protocol Clarifier; everything else on this page is the engine's own text, carried whole.